The effect of COX-2-dependent prostaglandins (PGs) in acute liver injury has been investigated in transgenic mice that express human COX-2 in hepatocytes. We have 
INTRODUCTION
The acute or chronic liver injury, caused by viral infection, autoimmune reactions, alcohol ingestion, or the use of certain drugs, results in severe pathologies including fulminant hepatitis, cirrhosis and hepatocellular carcinoma (HCC). Chronic hepatitis is a prolonged inflammatory process, with inflammatory cells infiltrating the liver parenchyma and triggering hepatocyte death. Persistent hepatocyte cell death is followed by a regenerative response in which viable hepatocytes are stimulated to proliferate to restore the loss of hepatic parenchyma [1] .
Cyclooxygenase-1 (COX-1) and -2 catalyze the first step in prostanoid biosynthesis [2] . COX-1 is constitutively expressed in many tissues and seems to be involved in the housekeeping function of prostaglandins (PGs) [3] , whereas COX-2 is induced by a variety of stimuli such as growth factors, pro-inflammatory stimuli, hormones and other cellular stresses [4] . Adult hepatocytes fail to induce COX-2 expression regardless of the pro-inflammatory factors used; however, Kupffer, stellate, immortalized mouse liver cells and fetal hepatocytes retain the ability to express COX-2 upon stimulation with LPS and pro-inflammatory cytokines [5, 6] . In addition to this, we reported that partial hepatectomy (PH) induced COX-2 in hepatocytes and this contributed to the progression of cell cycle after PH [7, 8] . Expression of COX-2 has been also detected in human and animal models of cirrhosis [9] , after hepatitis B and C virus infection [10, 11] , in hepatoma cell lines [12] and in well-differentiated HCC [13] .
Despite these observations, the question of whether COX-2 expression is sufficient to induce tumorigenesis and the contribution of COX-2-dependent PGs to the inflammatory injury in liver has not been properly addressed [1, 14] . To gain insight into the role of PGs in acute and chronic liver diseases, we have developed a transgenic mouse that expresses human COX-2 constitutively in hepatocytes under the control of the human ApoE promoter. These mice exhibited a normal phenotype but they were resistant to Fas-mediated apoptosis [15] . Although it is widely accepted that PGs contribute to the pathology of various inflammatory diseases, which provide the rational for the development of COX selective inhibitors [16] , different reports suggest that PGE2 plays a protective role in various animal models of liver injury [17] . Based on these data, we sought to examine the response of the COX-2-Tg mice in two well established models of inflammatory liver injury: LPS-injury in D-GalN preconditioned mice, an experimental model for fulminant hepatitis in sepsis, and the hepatitis induced by intravenous injection of ConA, a model relevant to autoimmune hepatitis. Our data clearly show that PGE2 produced by COX-2 in hepatocytes enhances the levels of anti-apoptotic proteins, decreases the susceptibility to apoptosis after LPS/D-GalN challenge; attenuates the T-cell dependent hepatitis in response to ConA administration, and accelerates the expression of proteins that are involved in the proliferation of hepatocytes in regenerating liver after PH. 
MATERIAL AND METHODS

Chemicals
Liver injury and regeneration models
To generate mice expressing a human COX-2-Tg in the liver, we used a pLiv-Le6 vector that contains the constitutive human ApoE gene promoter and its hepatic control region [15] . 12 weeks-old Tg animals (C57BL/6JxDBA) and its corresponding wild type (Wt) littermates were injected intraperitoneally (i.p.) with 1g/kg D-GalN plus 35 μg/kg LPS. ConA was intravenous (i.v.) injected through the tail vein at a dose of 20 mg/kg. Untreated animals received 0.5 ml of NaCl 0.9%. For PH, mice were anesthetized with a 92:7 mg/kg mix of ketamine/xylacine and subjected to midventral laparotomy with 70% liver resection (left lower and upper and right upper lobes) as described [7] . In some experiments, mice were treated daily for four days with DFU (1 mg/kg) to inhibit COX-2 [18] . Plasma was obtained by puncture of the retro-orbital vein plexus. Animals were sacrificed at six or eight h after LPS/D-GalN or ConA treatment, respectively. Livers were rapidly removed and freeze-clamped in liquid N2 or collected in a solution containing 30% sucrose in PBS. Animals were treated according to the Institutional Care Instructions.
Cytokine analysis
The plasma levels of IFN-, TNF-, IL-1 and IL-6 were measured by fluorimetry using Bio-Plex Suspension Array System (Cytokine Assay) according to the manufacturer's instructions (Bio-Rad).
Determination of metabolites
PGE2 was determined in liver tissue by specific immunoassay (Amersham). Briefly, liver samples were homogenized in 0.1 M phosphate buffer pH 7.5, containing 0.9% BSA and 0.5% Kathon (assay buffer). After centrifugation, the PGs were analyzed according to manufacturer's instructions. Amino transferases, ALT and ASP, alkaline phosphatase, ALP, and lactate dehydrogenase, LDH, were assayed spectrophotometrically in plasma in the School of Clinic Biochemistry, Faculty of Pharmacy, Complutense University, Madrid, Spain. Protein levels were determined with the Bradford reagent (Bio-Rad).
Histochemistry and immunofluorescence
Samples of liver were fixed in 10% buffered formalin, embedded in paraffin wax, sectioned at 3 μm and stained with hematoxylin and eosin (H&E). Histopathology 
Western blot analysis
Tissue samples (100 mg) were homogenized in a lysis buffer as described [15] . For 
Caspase assays.
Livers were homogenized in 20 mM HEPES pH 7.5; 2 mM DTT and 10 % glycerol.
The extracts were centrifuged at 8000g for 15 min at 4ºC and 0.5 mg/ml of protein supernatant was used to measure caspase activities by cleavage of specific fluorogenic substrates in accordance with the supplier's instructions (BD PharMingen). Substrates were N-acetyl-DEVD-7-amino-4-trifluoromethylcoumarin for caspase 3 and N-acetyl-IETD-7-amino-4-trifluoromethylcoumarin for caspase 8. The linearity of caspase assays was determined over a 30 min reaction period.
Data analysis
Data are expressed as means ± standard deviation (SD). Statistical significance ofdifferences between the control and transgenic groups was evaluated by the U of Mann-Whitney test. All tests have been calculated two-tail, and the significance has been considered at P< 0.05.
RESULTS
Expression of h-COX-2 and PGE2 levels in Tg mice after LPS/D-GalN treatment.
To achieve selective expression of COX-2 in hepatocytes, we generated transgenic (Tg) mice carrying the human isoform of COX-2 (h-COX-2) under the control of the human ApoE promoter and its endogenous hepatic control region [15] .
The levels of h-COX-2, COX-1 and microsomal PGE synthase, which catalyzes the isomerization of PGH2 to PGE2, were analyzed in liver extracts from Wt and Tg mice after LPS/D-GalN administration. As shown in Fig. 1A , h-COX-2 was significantly expressed in Tg animals but was not detectable in the Wt. Total COX-2 (human and endogenous) was also increased in Tg mice. Low levels of mPGES-1, which preferently couples with COX-2 activity to increase the production of PGE2, and COX-1 were present in Wt and Tg mice and did not change after treatment with LPS/D-GalN. The protein levels of cPGES were higher than those of mPGES-1 and did not change after the injury (Fig. 1A) ; mPGES-2 levels were negligible (not shown). Treatment of the animals with the COX-2 selective inhibitor DFU reduced ( 75%) the PGE2 synthesis (Fig. 1B) . were determined. As Fig. 2A shows, a significant increase of circulating cytokine levels was observed in Wt mice by the effect of the injury, but this was much lower, about 50%, in COX-2-Tg mice. When COX-2-Tg mice were treated with DFU, cytokine levels resembled those of the Wt animals. The activities of hepatic injury markers AST, ALT, ALP and LDH were analyzed after 6 h of LPS/D-GalN administration. After hepatic injury, the increase in plasma levels of aminotransferases observed in COX-2-Tg mice was much lower than in the Wt ( 80%). When COX-2 was inhibited by treatment with DFU, the protection in the Tg animals was lost (Table I) 
Inhibition of pro-inflammatory cytokines and liver injury in COX-
COX-2 dependent PGs prevent liver injury induced by ConA.
ConA induced liver injury is mediated by the activation of the innate and adaptive immune cells including natural killer cells (NK), Kupffer cells and CD4+ T cells and their production of inflammatory cytokines, such as IL-6, IL-2, TNF-and IFN- [19] . Tg animals expressing COX-2 in liver exhibited a significant decrease of ConA-induced injury, mainly in IFN-, IL-1 and IL-6 levels (Fig. 3A) , as well as on liver injury markers (Table II) . Histological analysis of liver sections of Wt and Tg mice treated with ConA is shown in Fig. 3B . Livers from Wt mice exhibited focal mild areas of necrosis in hepatocytes whereas no remarkable lesions were observed in Tg mice.
Caspase 3-like activity was minimally induced in both Wt and Tg mice by the effect of ConA (note the difference of magnitude vs. the LPS/D-GalN model), and a minimal processing of procaspase 3 was observed in the Wt mice ( Fig. 4C-D) .
Altered expression of apoptotic related proteins after liver injury in h-COX-2 Tg mice.
To address the anti-apoptotic mechanism of COX-2 acting upon LPS/D-GalN or
ConA mediated liver injury, we investigated the expression of apoptosis-related proteins. As Fig. 5A shows, the protein levels of TNFR1, TRADD and xIAP were equivalent in Wt and Tg mice and no differences were found after treatments. Bax was increased in Wt mice after injury and no changes were observed in Tg mice. Bcl-2 and
Mcl-1 levels were increased in Tg liver under basal conditions and were maintained after LPS/D-GalN treatment. TNFR2 and TRAF2 (TNF receptor-associated factor 2) decreased by the effect of the treatment in Wt but not in COX-2 expressing liver, indicating an increased sensitivity to TNF-induced apoptosis in Wt mice. Moreover, an increase in the Bcl-2/Bax (170%) ratio was observed in Tg mice after LPS/D-GalN treatment (Fig. 5C ). Similar results were obtained when all these parameters were measured in Wt and Tg mice treated with ConA ( Fig. 5B-D) .
The PI3K/Akt and AMPK pathways play a central role in integrating diverse survival signals. An increase in the p-Akt/Akt (>3 fold) and more moderate in the p-AMPK /AMPK (1.5 fold) ratio were observed in Tg mice after LPS/D-GalN (Fig.   6A ) or ConA injury (Fig. 6B) . To confirm the contribution of PGs synthesis on Akt phosphorylation, we performed experiments in liver cell lines with stable expression of COX-2 as described previously [20] . A significant inhibition of the apoptosis induced 
COX-2 Tg mice exhibit an accelerated hepatocyte proliferation after PH.
Because liver regeneration after PH implies a negligible apoptosis under normal conditions, we decided to evaluate the effect of the COX-2 Tg after PH. As previously described [7] , COX-2 protein levels increased after PH and the levels of COX-1 and mPGES did not change (Fig. 8C ). Fig. 8A shows similar survival rates for Wt and Tg mice after PH and no significant differences were found in the liver regeneration index at 80 h after PH (Fig. 8B) . When cell cycle proteins were analyzed, significant differences were found in the levels of proliferating cell nuclear antigen (PCNA), cyclin D1 and cyclin E between Tg and the corresponding Wt mice. As shown in Fig. 8D-E, cyclin D1 was present in Tg mice at 0 h, increased at 12 h and remained elevated at 24 h after PH; cyclin E increased at 12 h and the raise of PCNA after PH was evidenced at
DISCUSSION
We have studied the effect of constitutive expression of COX-2 in the hepatocyte on the liver response to three distinct insults: LPS/D-GalN, ConA and PH.
These Tg animals exhibited higher levels of some anti-apoptotic genes of the Bcl-2 family and were significantly resistant to LPS/D-GalN-induced injury, mainly through an inhibition of the apoptotic response characteristic of this model. It has been reported that D-GalN co-administered with LPS, represents an experimental model for fulminant hepatitis in sepsis due to massive hepatocyte apoptosis, mainly caused by an abrupt TNF-rise in the absence of transcription [21] . Under these conditions, COX-2 Tg animals exhibited a much lesser pro-inflammatory profile than the corresponding Wt animals. TNF-signals through two distinct membrane receptors: TNFR1 and TNFR2.
TNFR1, but not TNFR2 can directly activate the caspase 8 apoptotic pathway through its cytoplasmic death domain (DD) [22] . Through TRADD, TNFR1 engagement also leads to IKK and JNK activation. While IKK activation has a clear antiapoptotic function, different results have been reported for the role of JNK activation in TNF--induced apoptosis [23] . Our data show a decrease in TNFR2 by the effect of LPS/D-GalN treatment in Wt mice and this may be due to a down-regulation of the receptor described during endotoxemia [24] . Although TNFR2 lacks a death domain, it has also been associated with the apoptotic response to TNF-. It is known that TNFR2 triggering induces degradation and depletion of TRAF2 and IAP proteins and accelerates TNFR1-dependent activation of caspase 8 [25] . TRAF2 protein levels were depleted by the effect of the injury in Wt mice but not in the COX-2-Tg liver supporting the hypothesis that TRAF2 provides anti-apoptotic signals following TNF-stimulation. [27] . In agreement with this mechanism, treatment with ConA produced a rise in IFN-levels, an effect that was markedly reduced in COX-2 Tg mice, which suggests that PGs are interfering on immune cell activation, in particular lymphocytes. In this regard, it should be mentioned that previous work described an inhibitory effect by PGs on T cell activation [28] . The activation of caspase 3 observed in ConA-treated mice was less than 80% of that observed after LPS/D-GalN challenge and, indeed, a negligible procaspase 3 processing to caspase 3 was observed in ConA treated animals in our conditions, suggesting that ConA is mainly promoting a cytolytic/necrotic response in agreement with the rapid rise in plasma levels of transaminases. Although in both liver injury models the expression of the COX-2 Tg exerted a very important protection, it is noteworthy mention that the cellular and molecular mechanisms underlying this effect appear to be different: protection against apoptosis in the LPS/D-GalN model, and attenuation of the immunecell dependent hepatocyte necrosis in the case of ConA administration.
The pro-inflammatory and cytoprotective functions of COX-2 in liver remain unclear, mainly because hepatocytes, but not other hepatic cells, fail to express COX-2 upon pro-inflammatory challenge [29] . It has been reported that expression of a COX-2 Tg causes hepatitis in senescent animals [30] ; however, different reports demonstrated that PGE2 administration protects against liver injury after E. coli infection by suppressing circulating TNF-and IL-12 levels and increasing IL-10 production [31] .
The PGE2-EP4 signalling pathway effectively protects against hepatic ischemia/reperfusion injury because EP4 agonists downregulated the expression of several pro-inflammatory cytokines, chemokines and adhesion molecules [17] . PGE2
downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration and LPS liver injury [32] and attenuates the acute phase response through a decrease in IL-6-induced -2 macroglobulin formation via a cAMP-dependent signalling [33] . Our results agree with these data and show that COX-2-dependent PGs cause an important decrease in the plasma levels of pro-inflammatory cytokines and a significant improvement in liver function after LPS/D-GalN or ConA challenge compared with the Wt counterparts. In this regard, Yin et al. [34] by using COX-2-/-mice demonstrated an increased susceptibility of COX-2-/-mice to ConA-induced hepatitis.
Studies with different Tg mouse models of COX-2 also demonstrated the important anti-apoptotic role for PGs. Tg mice expressing COX-2 in mammary gland developed tumours, and these animals had reduced levels of the proapoptotic proteins Bax and Bcl-xS and elevated levels of the antiapoptotic protein Bcl-2 [35] . A different study demonstrated hyperplasic gastric tumours in Tg mice expressing COX-2 and PGES. This study relates PGE2 with the recruitment, infiltration and activation of mucosal macrophages establishing a relationship between inflammation and tumour cell growth [36] . Our previous results obtained with stable expression of COX-2 in liver cell lines and with mouse hydrodynamically transfected with a COX-2-GFP expression vector, supported the view that PGs produced by COX-2 protected the liver against Fas-mediated apoptosis [20] . In this work we show that PGs produced by COX-2 in liver, increased the levels of Bcl-2, Mcl-1, TNFR2 and TRAF2, all these hallmarks of apoptotic/anti-apoptotic pathway, and were confirmed by a PCR array analysis specific for apoptosis profile. Several signalling pathways have been proposed as mediators of COX-2-dependent inhibition of apoptosis; however, few reports describe the direct effect of COX-2 expression on apoptosis in liver or HCC cells. Leng et al. [37] reported an enhanced phosphorylation of Akt in Hep3B cells transiently or permanently transfected with a COX-2 expression vector; overexpression of COX-2 in rat intestinal epithelial cells increased their resistance to undergo apoptosis and resulted in increased Bcl-2 protein levels [38] and COX-2 induces a Mcl-1-dependent survival mechanism in human lung adenocarcinoma cells [39] . Targets of PGs through their EP receptors are the PI3K and the Akt/PKB pathways. The PI3K/Akt is important in modulating the mammalian target of rapamycin, which acts as a central sensor for nutrient/energy availability, thereby regulating cell growth. Activation of Akt and G subunit of EP receptors can also result in the accumulation of -catenin of the canonical Wnt pathway in the nucleus, which also leads to transcriptional activation [40] . Akt improves cellular energy stores by accelerating cell proliferation and size, while induces antiapoptotic effects by phosphorylation and inactivation of the proapoptotic protein Bad, and by the upregulation of Bcl-2 and Mcl-1 [41] . Our results show that in the liver of COX-2-Tg mice, both Akt and AMP-kinase are phosphorylated indicating a reinforcement of survival pathways and a higher efficiency in energetic metabolism, preventing ATP depletion [42] . These circumstances concur in favouring liver protection after acute injury.
It has been described [7, 43] that PGs produced by COX-2 are important for the early steps of liver regeneration after PH. Because liver regeneration after PH is characterized by a negligible concurrence of apoptosis, we investigated whether the COX-2 Tg might influence the hepatocyte proliferation. Our results show that PGs anticipated the initial cell cycle progression without noticeable changes in the rate of mass recovery at the end (5-days) of the regeneration process. As potential mechanisms responsible for this rapid cell commitment for proliferation, it is known that PGs increase cyclin D1 levels through -catenin pathway [44] , and that both AMPK and Akt facilitate cell entry into the cell cycle [45] , and these enzymes are 'more active' in the COX-2-Tg mice. It is relevant to note that continuous generation of PGE2 in the hepatocytes contributes to higher levels of cyclins and a more intense expression of PCNA. However, these circumstances did not contribute to acceleration in the regeneration process, suggesting that rate-limiting factors play a role after PH and provide a fine kinetic control for hepatocyte proliferation.
Finally, although these studies have been performed using acute liver injury approaches and showed tissue protection, further studies with this COX-2-Tg mice, might help to elucidate whether this COX-2 expression protects or might sensitize mouse liver for chronic diseases and carcinogenesis. 
